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Letter to the EditorThe AMPK-Malonyl-CoA-CPT1 Axis
in the Control of Hypothalamic
Neuronal FunctionDear Editor,
We would like to offer alternative per-
spectives to those suggested in a recent
article in Cell Metabolism on the potential
roles of FAS, malonyl-CoA and CPT1 in
hypothalamic function. In Lopez et al.
(2008) the fasting- and ghrelin-mediated
(AMPK-dependent) downregulation of
FAS expression was proposed to be ‘‘an
adaptive mechanism that helps to prevent
malonyl-CoA from decreasing to deleteri-
ously low levels in the hypothalamus.’’ We
suggest that the downregulation of FAS
serves to prime neurons to respond to re-
feeding by enabling a more rapid increase
in [malonyl-CoA] when feeding signals
reach the hypothalamus; this would
control meal size more efficiently. The ra-
tionale for a CPT1C-associated signaling
role for malonyl-CoA independently from
its inhibition of CPT1 activity is not sup-
ported by existing data. CPT1C (the activ-
ity of which is difficult to detect in vitro
even with the use of sensitive radiochem-
ical assays, owing to its extremely low
catalytic constant [Sierra et al., 2008])
binds malonyl-CoA with the same affinity
as CPT1A (Price et al., 2002). We have
suggested that it could buffer the avail-
ability of malonyl-CoA in specific micro-
environments within the cell (Price et al.,
2002). Malonyl-CoA is capable of signal-
ing indirectly through its inhibition of the
highly active isoforms CPT 1A and/or
1B; such inhibition raises the concentra-
tions of cytosolic long-chain acyl-CoA
(LC-CoA) esters, potentially making CPT 1
activity central to neuroendocrine cell
responses, as these metabolites are (1)
activators of the K+ATP channels and
therefore able to affect neuronal electrical
activity, and (2) sensitizers of vesicular
(neuro)peptide secretion.In (Lopez et al., 2008) correlations were
drawn between short-term changes in
CPT activity measured in vitro, and tissue
malonyl-CoA content measured in the
VMH. However, during assay of CPT activ-
ity, the malonyl-CoA would have been infi-
nitely diluted in tissue extracts and assay
media. However, mechanisms that specif-
ically enable CPT1A (not 1C) to adapt its
sensitivity to malonyl-CoA inhibition to
different physiological conditions, coinci-
dent with changes in cellular [malonyl-
CoA], do exist and amplify the effects of
changes in the concentration of the inhib-
itor in vivo; see Zammit (1999) for review.
More generally, these mechanisms are
also likely to be important in adapting the
function of CPT1A-expressing hypotha-
lamic neurons to factors such as dietary
fat composition, obesity, and fasting, as
they do in other cell types in which
CPT1A is expressed. Similarly, the modu-
lation of CPT1A sensitivity to malonyl-CoA
through altered mitochondrial outer mem-
brane composition (Zammit, 1999) has the
potential to be involved in the reported at-
tenuation of the CPT1A-mediated anorex-
igenic signal in rats maintained for 3 days
on a high-fat diet (Pocai et al., 2006).
The high CPT activity measured in the
VMH by Lopez et al. (2008) using a colori-
metric assay was correlated with the im-
munoquantification of only one (CPT1C)
of the three isoforms of CPT1 that are ex-
pressed in the hypothalamus (Price et al.,
2002). Owing to the very low intrinsic cat-
alytic activity of CPT1C, it is highly likely
that the activity measured was due to
CPT1A and/or CPT1B, whereas immuno-
quantification was specifically of CPT1C
protein. This discrepancy may require
a re-evaluation of some of the data pre-
sented. The absence of an effect of icvCell Metabolism 8, Setomoxir alone on food intake in Lopez
et al. (2008) differs from previous observa-
tions (Pocai et al., 2006), namely that icv-
delivered pharmacological and antisense
oligomer-mediated specific inhibition of
hypothalamic CPT1A results in a rapid
inhibition of food intake and hepatic glu-
cose production. This discrepancy sug-
gests that the exact site of icv delivery
may determine the an/orexigenic re-
sponse, depending on which precise cell
types are affected and on which CPT1
isoform(s) are expressed therein. It is
also possible that opposite directions of
changes in CPT 1 activity, and thus of
[acyl-CoA], are required for activation/
inhibition of the electrical activity of par-
ticular types of neurons. We hope that a
thorough appreciation of the metabolic
principles involved in the regulation of
the AMPK-malonyl-CoA-CPT 1 axis may
improve our understanding of hypotha-
lamic neuronal function in response and
adaptation to dietary signals.
Victor A. Zammit1,*
and Arduino Arduini2
1Clinical Sciences Research Institute,
Warwick Medical School, University of
Warwick, CV4 7AL, UK
2Iperboreal Pharma srl, R&D Department,





Lopez, M., Lage, R., Saha, A.K., Perez-Tilve, D.,
Vazquez, M.J., Varela, L., Sangiao-Alvarellos, S.,
Tovar, S., Raghay, K., Rodriguez-Cuenca, S.,
et al. (2008). Cell Metab. 7, 389–399.
Pocai, A., Lam, T.K., Obici, S., Gutierrez-Juarez,
R., Muse, E.D., Arduini, A., and Rossetti, L.
(2006). J. Clin. Invest. 116, 1081–1091.
Price, N., van der Leij, F., Jackson, V., Corstor-
phine, C.C., Thomson, R., Sorensen, A., and Zam-
mit, V.A. (2002). Genomics 80, 433–442.
Sierra, A.Y., Gratacos, E., Carrasco, P., Clotet, J.,
Urena, J., Serra, D., Asins, G., Hegardt, F.G., and
Casals, N. (2008). J. Biol. Chem. 283, 6878–6885.
Zammit, V.A. (1999). Biochem. J. 343, 505–515.eptember 3, 2008 ª2008 Elsevier Inc. 175
